Perhaps you heard Dr. Saltz’s ASCO talk in <a href='read_msg.asp?message_id=8140742'>#msg-8140742</a>, which covered the very issues you’ve addressed. Are you by any chance an oncologist? Have you been following the smoke-signal reading vis-à-vis Panitumumab?